{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:49:07Z","timestamp":1791283747958,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00105-021-04856-8","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T14:02:39Z","timestamp":1628604159000},"page":"815-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Akne","Acne"],"prefix":"10.1007","volume":"72","author":[{"given":"Ante","family":"Karoglan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald P. M.","family":"Gollnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"4856_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/jdv.12160","volume":"28","author":"J Karciauskiene","year":"2014","unstructured":"Karciauskiene\u00a0J, Valiukeviciene\u00a0S, Gollnick\u00a0H et al (2014) The prevalence and risk factors of adolescent acne among schoolchildren in Lithuania: a\u00a0cross-sectional study. J\u00a0Eur Acad Dermatol Venereol 28:733\u2013740","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4856_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1468-3083.2010.03919.x","volume":"25","author":"AC Perkins","year":"2011","unstructured":"Perkins\u00a0AC, Cheng\u00a0CE, Hillebrand\u00a0GG et\u00a0al (2011) Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J\u00a0Eur Acad Dermatol Venereol 25:1054\u20131060","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4856_CR3","first-page":"301","volume":"111","author":"HP Gollnick","year":"2014","unstructured":"Gollnick\u00a0HP, Zouboulis\u00a0CC (2014) Not all acne is acne vulgaris. Dtsch Arztebl Int 111:301\u2013312","journal-title":"Dtsch Arztebl Int"},{"key":"4856_CR4","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/978-3-642-02202-9_143","volume-title":"Textbook of clinical pediatrics","author":"HPM Gollnick","year":"2012","unstructured":"Gollnick\u00a0HPM (2012) Acne and related disorders. In: Elzouki\u00a0AY (Hrsg) Textbook of clinical pediatrics, 2.\u00a0Aufl. Springer, Berlin, S\u00a01447\u20131466","edition":"2"},{"key":"4856_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/pde.12238","volume":"31","author":"AF Bree","year":"2014","unstructured":"Bree\u00a0AF, Siegfried\u00a0EC (2014) Acne vulgaris in preadolescent children: recommendations for evaluation. Pediatr Dermatol 31:27\u201332","journal-title":"Pediatr Dermatol"},{"key":"4856_CR6","volume-title":"Pathogenesis and treatment of acne and rosacea","year":"2014","unstructured":"Zouboulis\u00a0CC, Katsambas\u00a0AD, Kligman\u00a0AM (Hrsg) (2014) Pathogenesis and treatment of acne and rosacea. Springer, Berlin, Heidelberg"},{"key":"4856_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2165\/00128071-200809050-00001","volume":"9","author":"HPM Gollnick","year":"2008","unstructured":"Gollnick\u00a0HPM, Finlay\u00a0AY, Shear\u00a0N (2008) Can we define acne as a\u00a0chronic disease? If so, how and when? Am J Clin Dermatol 9:279\u2013284","journal-title":"Am J Clin Dermatol"},{"key":"4856_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-49274-2","volume-title":"Plewig and Kligman\u2019s acne and rosacea","author":"G Plewig","year":"2019","unstructured":"Plewig\u00a0G, Melnik\u00a0B, Chen\u00a0W (2019) Plewig and Kligman\u2019s acne and rosacea, 4.\u00a0Aufl. Springer, Cham","edition":"4"},{"key":"4856_CR9","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdv.13776","volume":"30","author":"A Nast","year":"2016","unstructured":"Nast\u00a0A, Dr\u00e9no\u00a0B, Bettoli\u00a0V et al (2016) European evidence-based (S3) guideline for the treatment of acne\u2014update 2016 \u2013 short version. J\u00a0Eur Acad Dermatol Venereol 30:1261\u20131268","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4856_CR10","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/jdv.13675","volume":"30","author":"HP Gollnick","year":"2016","unstructured":"Gollnick\u00a0HP, Bettoli\u00a0V, Lambert\u00a0J et al (2016) A consensus-based practical and daily guide for the treatment of acne patients. J\u00a0Eur Acad Dermatol Venereol 30:1480\u20131490","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4856_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMcp1702493","volume":"379","author":"AL Zaenglein","year":"2018","unstructured":"Zaenglein\u00a0AL (2018) Acne vulgaris. N\u00a0Engl J Med 379:1343\u20131352","journal-title":"N Engl J Med"},{"key":"4856_CR12","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2165\/00003495-200363150-00005","volume":"63","author":"H Gollnick","year":"2003","unstructured":"Gollnick\u00a0H (2003) Current concepts of the pathogenesis of acne: implications for drug treatment. Drugs 63:1579\u20131596","journal-title":"Drugs"},{"key":"4856_CR13","first-page":"1185","volume":"16","author":"B Dreno","year":"2018","unstructured":"Dreno\u00a0B, Bagatin\u00a0E, Blume-Peytavi\u00a0U et al (2018) Akne bei erwachsenen Frauen: Physiologische und psychologische Erw\u00e4gungen und Management. J\u00a0Dtsch Dermatol Ges 16:1185\u20131196","journal-title":"J Dtsch Dermatol Ges"},{"key":"4856_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4172\/2155-9554.100010","volume":"1","author":"CB Melnik","year":"2010","unstructured":"Melnik\u00a0CB (2010) Acneigenic stimuli converge in phosphoinositol\u20113 kinase\/ Akt\/Foxo1 signal transduction. J\u00a0Clin Exp Dermatol Res 1:101. https:\/\/doi.org\/10.4172\/2155-9554.100010","journal-title":"J Clin Exp Dermatol Res"},{"key":"4856_CR15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/1523-1747.ep12472325","volume":"100","author":"H Akamatsu","year":"1993","unstructured":"Akamatsu\u00a0H, Zouboulis\u00a0CC, Orfanos\u00a0CE (1993) Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5 alpha-dihydrotestosterone in vitro. J\u00a0Invest Dermatol 100:660\u2013662","journal-title":"J Invest Dermatol"},{"issue":"4","key":"4856_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.13190","volume":"29","author":"B Dreno","year":"2015","unstructured":"Dreno\u00a0B, Gollnick\u00a0HPM, Kang\u00a0S et\u00a0al (2015) Understanding innate immunity and inflammation in acne: implications for management. J\u00a0Eur Acad Dermatol Venereol 29(4):3\u201311","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4856_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/j.1468-3083.2011.04444.x","volume":"26","author":"V Bataille","year":"2012","unstructured":"Bataille\u00a0V, Lens\u00a0M, Spector\u00a0TD (2012) The use of the twin model to investigate the genetics and epigenetics of skin diseases with genomic, transcriptomic and methylation data. J\u00a0Eur Acad Dermatol Venereol 26:1067\u20131073","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4856_CR18","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1111\/jdv.14385","volume":"31","author":"R Lichtenberger","year":"2017","unstructured":"Lichtenberger\u00a0R, Simpson\u00a0MA, Smith\u00a0C et\u00a0al (2017) Genetic architecture of acne vulgaris. J\u00a0Eur Acad Dermatol Venereol 31:1978\u20131990","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4856_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2230.1994.tb01200.x","volume":"19","author":"AM Layton","year":"1994","unstructured":"Layton\u00a0AM, Henderson\u00a0CA, Cunliffe\u00a0WJ (1994) A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 19:303\u2013308","journal-title":"Clin Exp Dermatol"},{"key":"4856_CR20","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jaad.2019.04.012","volume":"82","author":"D Thiboutot","year":"2020","unstructured":"Thiboutot\u00a0D, Dr\u00e9no\u00a0B, Sanders\u00a0V et\u00a0al (2020) Changes in the management of acne: 2009\u20132019. J\u00a0Am Acad Dermatol 82:1268\u20131269","journal-title":"J Am Acad Dermatol"},{"key":"4856_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.mce.2015.08.001","volume":"415","author":"Y Mirdamadi","year":"2015","unstructured":"Mirdamadi\u00a0Y, Thielitz\u00a0A, Wiede\u00a0A et al (2015) Insulin and insulin-like growth factor\u20111 can modulate the phosphoinositide-3-kinase\/Akt\/FoxO1 pathway in SZ95 sebocytes in vitro. Mol Cell Endocrinol 415:32\u201344","journal-title":"Mol Cell Endocrinol"},{"key":"4856_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-019-00423-z","volume":"20","author":"SS Kolli","year":"2019","unstructured":"Kolli\u00a0SS, Pecone\u00a0D, Pona\u00a0A et\u00a0al (2019) Topical retinoids in acne vulgaris: a systematic review. Am J Clin Dermatol 20:345\u2013365","journal-title":"Am J Clin Dermatol"},{"key":"4856_CR23","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2147\/TCRM.S94062","volume":"12","author":"SY Kim","year":"2016","unstructured":"Kim\u00a0SY, Ochsendorf\u00a0FR (2016) New developments in acne treatment: role of combination adapalene-benzoylperoxide. Ther Clin Risk Manag 12:1497\u20131506","journal-title":"Ther Clin Risk Manag"},{"key":"4856_CR24","first-page":"1319","volume":"14","author":"HPM Gollnick","year":"2016","unstructured":"Gollnick\u00a0HPM, Buer\u00a0J, Beissert\u00a0S et\u00a0al (2016) Verantwortlicher Umgang mit Antibiotika: Notwendigkeit der Antibiotikareduktion in der Aknetherapie. J\u00a0Dtsch Dermatol Ges 14:1319\u20131327","journal-title":"J Dtsch Dermatol Ges"},{"key":"4856_CR25","first-page":"964","volume":"14","author":"BC Schulte","year":"2015","unstructured":"Schulte\u00a0BC, Wu\u00a0W, Rosen\u00a0T (2015) Azelaic acid: evidence-based update on mechanism of action and clinical application. J\u00a0Drugs Dermatol 14:964\u2013968","journal-title":"J Drugs Dermatol"},{"key":"4856_CR26","first-page":"538","volume":"11","author":"HP Gollnick","year":"2001","unstructured":"Gollnick\u00a0HP, Graupe\u00a0K, Zaumseil\u00a0RP (2001) Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 11:538\u2013544","journal-title":"Eur J Dermatol"},{"key":"4856_CR27","first-page":"565","volume":"16","author":"B Dr\u00e9no","year":"2006","unstructured":"Dr\u00e9no\u00a0B, Bettoli\u00a0V, Ochsendorf\u00a0F et\u00a0al (2006) An expert view on the treatment of acne with systemic antibiotics and\/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 16:565\u2013571","journal-title":"Eur J Dermatol"},{"issue":"1","key":"4856_CR28","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1111\/j.1610-0387.2006.06053_suppx.x","volume":"8","author":"F Ochsendorf","year":"2010","unstructured":"Ochsendorf\u00a0F (2010) Systemic antibiotic therapy of acne vulgaris. J\u00a0Dtsch Dermatol Ges 8(1):S31\u201346","journal-title":"J Dtsch Dermatol Ges"},{"key":"4856_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/jdv.12823","volume":"29","author":"A Thielitz","year":"2015","unstructured":"Thielitz\u00a0A, Lux\u00a0A, Wiede\u00a0A et al (2015) A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15\u202f% gel vs. adapalene 0.1\u202f% gel in the treatment and maintenance treatment of female adult acne. J\u00a0Eur Acad Dermatol Venereol 29:789\u2013796","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4856_CR30","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2340\/00015555-3323","volume":"99","author":"A Karoglan","year":"2019","unstructured":"Karoglan\u00a0A, Paetzold\u00a0B, Pereira de Lima\u00a0J et al (2019) Safety and efficacy of topically applied selected cutibacterium acnes strains over five weeks in patients with acne vulgaris: an open-label, pilot study. Acta Derm Venereol 99:1253\u20131257","journal-title":"Acta Derm Venereol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04856-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04856-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04856-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T21:47:10Z","timestamp":1630705630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04856-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4856"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04856-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"assertion":[{"value":"7 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>A.\u00a0Karoglan<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: La Roche-Posay, Medac, AbbVie, UCB-Pharma, Novartis. \u2013\u00a0Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: Novartis, Roche, La Roche-Posay.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Dermatologe, MVZ Herderstra\u00dfe (ab Juli MVZ \u201eIm Altstadtquartier\u201c, Magdeburg)\u00a0| Mitgliedschaft: Marburger Bund. <b>H.P.M.\u00a0Gollnick<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar: Mylan Ltd, Bayer HC, Galderma, IMTM, S\u2011Biomedic. \u2013\u00a0Adboard: S\u2011Biomedic.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Professor Emeritus, Otto-von-Guericke Universit\u00e4t Magdeburg\u00a0| Mitgliedschaften: DDG, BVDD, EADV, EDF, UEMS.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}